Early impact of the ICD‐10‐CM transition on selected health outcomes in 13 electronic health care databases in the United States
- 26 June 2018
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 27 (8) , 839-847
Abstract
Purpose: To describe the consistency in the frequency of 5 health outcomes across the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD‐9‐CM) and Tenth Revision, Clinical Modification (ICD‐10‐CM) eras in the US.Methods: We examined the incidence of 3 acute conditions (acute myocardial infarction [AMI], angioedema, ischemic stroke) and the prevalence of 2 chronic conditions (diabetes, hypertension) during the final 5 years of the ICD‐9‐CM era (January 2010‐September 2015) and the first 15 months of the ICD‐10‐CM era (October 2015‐December 2016) in 13 electronic health care databases in the Sentinel System. For each health outcome reviewed during the ICD‐10‐CM era, we evaluated 4 definitions, including published algorithms derived from other countries, as well as simple‐forward, simple‐backward, and forward‐backward mapping using the General Equivalence Mappings. For acute conditions, we also compared the incidence between April to December 2014 and April to December 2016.Results: The analyses included data from approximately 172 million health plan members. While the incidence or prevalence of AMI and hypertension performed similarly across the 2 eras, the other 3 outcomes did not demonstrate consistent trends for some or all the ICD‐10‐CM definitions assessed.Conclusions: When using data from both the ICD‐9‐CM and ICD‐10‐CM eras, or when using results from ICD‐10‐CM data to compare to results from ICD‐9‐CM data, researchers should test multiple ICD‐10‐CM outcome definitions as part of sensitivity analysis. Ongoing assessment of the impact of ICD‐10‐CM transition on identification of health outcomes in US electronic health care databases should occur as more data accrue.Keywords
Funding Information
- U.S. Food and Drug Administration (HHSF223200910006I)
This publication has 22 references indexed in Scilit:
- Drug-Induced Acute Myocardial Infarction: Identifying ‘Prime Suspects’ from Electronic Healthcare Records-Based Surveillance SystemPLOS ONE, 2013
- A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative dataPharmacoepidemiology and Drug Safety, 2012
- Design considerations, architecture, and use of the Mini‐Sentinel distributed data systemPharmacoepidemiology and Drug Safety, 2012
- A policy framework for public health uses of electronic health dataPharmacoepidemiology and Drug Safety, 2012
- The organizational structure and governing principles of the Food and Drug Administration's Mini‐Sentinel pilot programPharmacoepidemiology and Drug Safety, 2012
- The validation of the Finnish Hospital Discharge Register and Causes of Death Register data on stroke diagnosesEuropean Journal of Preventive Cardiology, 2007
- Risk of first-time hospitalization for angioedema among users of ACE inhibitors and angiotensin receptor antagonistsThe American Journal of Medicine, 2005
- Coding of Stroke and Stroke Risk Factors Using International Classification of Diseases , Revisions 9 and 10Stroke, 2005
- Burden of allergic disease in the UK: secondary analyses of national databasesClinical & Experimental Allergy, 2004
- Validating Administrative Data in Stroke ResearchStroke, 2002